Singin' the blues: The downside of hepatitis C virus treatment

American Journal of Gastroenterology

Volumn 102, Issue 11, 2007, Pages 2434-2436

  Bini, Edmund J ^a,b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; RIBAVIRIN;

HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; MENTAL DISEASE; MENTAL HEALTH CARE PERSONNEL; PRIORITY JOURNAL; REVIEW;

ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; MALE; MIDDLE AGED; PREVALENCE; UNITED STATES; VETERANS;

EID: 35448977168     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01418.x     Document Type: Review

References (17)

1. Vasiliadis HM, Lesage A, Adair C, et al. Do Canada and the United States differ in prevalence of depression and utilization of services? Psychiatr Serv 2007 58 : 63 71.
2. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003 289 : 3095 105.
3. Olfson M, Marcus SC, Druss B, et al. National trends in the outpatient treatment of depression. JAMA 2002 287 : 203 9.
4. Lee DH, Jamal H, Regenstein FG, et al. Morbidity of chronic hepatitis C as seen in a tertiary care medical center. Dig Dis Sci 1997 42 : 186 91.
5. Kraus MR, Schafer A, Csef H, et al. Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C. Psychosomatics 2000 41 : 377 84.
6. El Serag HB, Kunik M, Richardson P, et al. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology 2002 123 : 476 82.
7. Bini EJ, Brau N, Currie S, et al. Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection. Am J Gastroenterol 2005 100 : 1772 9.
8. Russo MW, Fried MW. Side effects of therapy for chronic hepatitis C. Gastroenterology 2003 124 : 1711 9.
9. Hoofnagle JH, Seeff LB. Peginterferon and ribavirin for chronic hepatitis C. N Engl J Med 2006 355 : 2444 51.
10. Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial. Lancet 2001 358 : 958 65.
11. Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2 a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 82.
12. National Institutes of Health. National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002-June 10-12, 2002. Hepatology 2002 36 : S3 20.
13. Van Thiel DH, Friedlander L, Molloy PJ, et al. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness. Eur J Gastroenterol Hepatol 1995 7 : 165 8.
14. Pariante CM, Orru MG, Baita A, et al. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999 354 : 131 2.
15. Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003 37 : 443 51.
16. Dieperink E, Ho SB, Thuras P, et al. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C. Psychosomatics 2003 44 : 104 12.
17. Jakiche A, Cruz Paredez E, Tannan PK, et al. The trend of depression and the use of psychiatric medications in US veterans with hepatitis C during interferon based therapy. Am J Gastroenterol 2007 102 : 2426 33.